LifeVantage Corporation reported a significant decline in financial performance for the second quarter of fiscal year 2026, as detailed in its latest 10-Q filing. The company generated net revenue of $48.9 million for the three months ended December 31, 2025, a decrease of 28% from $67.8 million in the same period the previous year. For the six months ended December 31, 2025, revenue totaled $96.5 million, down from $115.0 million in the prior year. The decline was primarily attributed to reduced sales of the MindBody GLP-1 System™, which saw a drop of $16.2 million in the quarter. Despite this, the company noted a slight positive impact from foreign currency fluctuations, which contributed an additional $0.2 million to revenue.
In terms of profitability, LifeVantage reported a net income of $276,000 for the three months ended December 31, 2025, a sharp decline from $2.55 million in the same quarter of 2024. For the six-month period, net income was $2.43 million, down from $4.38 million year-over-year. The decrease in profitability was influenced by higher costs associated with inventory obsolescence and increased shipping and warehouse expenses, which contributed to a gross profit margin decline from 80.5% to 74.0% for the quarter.
Operationally, the company experienced a reduction in its active accounts, with total active independent consultants and customers decreasing by 21.2% to 115,000 as of December 31, 2025, compared to 146,000 a year earlier. The Americas region saw a particularly steep decline in active customers, dropping by 32.5% to 54,000. This reduction in customer engagement is a critical indicator of the company's challenges in maintaining its sales force and customer base.
Strategically, LifeVantage made a notable acquisition in October 2025, purchasing the critical assets of LoveBiome, a company focused on microbiome care. This acquisition, valued at approximately $4.24 million, is expected to enhance LifeVantage's product offerings and market presence. The company has also launched new product stacks, including the Healthy Edge Stack, which combines products from both LifeVantage and LoveBiome, aiming to leverage synergies from the acquisition.
Looking ahead, LifeVantage remains focused on refining its product offerings and expanding its market reach, particularly with the integration of LoveBiome's products. The company anticipates that its ongoing efforts to enhance its sales compensation plan and product development will help stabilize revenue and improve customer retention in the coming quarters. However, the management acknowledged that the current market conditions and the need to attract new independent consultants and customers remain critical to its future growth.
About Lifevantage Corp
LifeVantage Corporation specializes in nutrigenomics, developing and selling scientifically validated dietary supplements, skin care, and nootropics aimed at supporting health, wellness, and anti-aging. Its core business model involves a direct sales network of independent consultants who promote and distribute products globally. The company emphasizes activation and cellular health, leveraging proprietary formulations, innovative technology, and a rewarding compensation plan to attract entrepreneurs and health-conscious consumers.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.